ZA902593B - The use of liposomes for the delivery of therapeutic agents to wounds,cuts and abrasions - Google Patents

The use of liposomes for the delivery of therapeutic agents to wounds,cuts and abrasions

Info

Publication number
ZA902593B
ZA902593B ZA902593A ZA902593A ZA902593B ZA 902593 B ZA902593 B ZA 902593B ZA 902593 A ZA902593 A ZA 902593A ZA 902593 A ZA902593 A ZA 902593A ZA 902593 B ZA902593 B ZA 902593B
Authority
ZA
South Africa
Prior art keywords
abrasions
wounds
liposomes
cuts
delivery
Prior art date
Application number
ZA902593A
Other languages
English (en)
Inventor
Jack Michael Shaw
Michael Shaw Jack
Diana Maria Cordova
Maria Cordova Diana
Original Assignee
Alcon Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Lab Inc filed Critical Alcon Lab Inc
Publication of ZA902593B publication Critical patent/ZA902593B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA902593A 1989-04-04 1990-04-04 The use of liposomes for the delivery of therapeutic agents to wounds,cuts and abrasions ZA902593B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33316489A 1989-04-04 1989-04-04

Publications (1)

Publication Number Publication Date
ZA902593B true ZA902593B (en) 1991-01-30

Family

ID=23301595

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA902593A ZA902593B (en) 1989-04-04 1990-04-04 The use of liposomes for the delivery of therapeutic agents to wounds,cuts and abrasions

Country Status (8)

Country Link
EP (1) EP0465588A4 (ko)
JP (1) JPH04505319A (ko)
KR (1) KR920700691A (ko)
AU (1) AU633078B2 (ko)
CA (1) CA2013770A1 (ko)
IL (1) IL93996A0 (ko)
WO (1) WO1990011781A1 (ko)
ZA (1) ZA902593B (ko)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05503527A (ja) * 1990-02-22 1993-06-10 マクノート・ピーティーワイ・リミテッド 人工涙液
IT1240683B (it) * 1990-04-26 1993-12-17 Zambon Spa Composizione farmaceutica contenente egf
DE9312509U1 (de) * 1993-08-20 1993-10-28 Euro-Celtique S.A., Luxemburg/Luxembourg Präparate zur äußeren Verabreichung von antiseptischen und/oder die Wundheilung fördernden Wirkstoffen
US5863556A (en) * 1993-08-20 1999-01-26 Euro-Celtique, S.A. Preparations for the external application of antiseptic agents and/or agents promoting the healing of wounds
US5589189A (en) * 1994-09-14 1996-12-31 Nexstar Pharmaceuticals, Inc. Liposome dispersion
CA2225398C (en) * 1996-04-19 2008-07-15 R-Tech Ueno, Ltd. Pharmaceutical composition comprising albumin as an active ingredient
EP0982025A1 (en) * 1998-08-28 2000-03-01 Wilhelm Prof. Dr. Stoffel Synthetic tear fluid
MXPA01012170A (es) 1999-05-27 2002-06-21 Euro Celtique Sa Preparacion para la aplicacion de agentes anti-infecciosos y/o anti-inflamatorios para partes externas o internas del cuerpo humano o animal en la remodelacion funcional y cosmetica y tratamientos de reparacion de tejidos.
US7297344B1 (en) 1999-05-27 2007-11-20 Euro-Celtique, S.A. Preparations for the promotion of wound healing in the upper respiratory tract and/or ear
US7300667B1 (en) 1999-05-27 2007-11-27 Euro-Celtique, S.A. Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the lower respiratory tract
GB9919131D0 (en) * 1999-08-14 1999-10-13 Depuy Int Ltd Joint lubrication
WO2002074281A1 (en) * 2001-03-15 2002-09-26 Novartis Ag Ophthalmic compositions and use thereof
KR100915741B1 (ko) * 2001-06-15 2009-09-04 코너스톤 파마슈티칼스 표적 조직 및 세포를 치료하기에 유용한 나노입자를함유하는 약제학적 및 진단학적 조성물
DE10141018A1 (de) * 2001-08-22 2003-03-13 Eth Zuerich Eidgenoessische Te Verwendung von negativ geladenen Phospholipiden, sowie Zusammensetzungen umfassend Phospholipide zur Behandlung des Auges
WO2003024422A1 (en) * 2001-09-18 2003-03-27 Vasogen Ireland Limited Process for accelerating recovery from trauma by using apoptosis-mimicking synthetic or natural entities
CU23043A1 (es) 2001-12-20 2005-05-20 Ct Ingenieria Genetica Biotech Composicion farmaceutica que contiene factor de crecimiento epidrmico (egf) para la prevencion de la amputacion de pie diabetico.
CA2368656A1 (en) * 2002-01-21 2003-07-21 Vasogen Ireland Limited Receptor-ligand pairing for anti-inflammatory response
AU2003201569B2 (en) * 2002-01-21 2008-09-11 Vasogen Ireland Limited Pharmaceutically acceptable phosphate-glycerol carrying bodies
CA2499136A1 (en) * 2002-09-16 2004-03-25 Vasogen Ireland Limited Accelerating recovery from trauma
AU2003275850A1 (en) * 2002-10-25 2004-05-13 Vasogen Ireland Limited Cyclooxygenase regulation with ps liposomes
AU2003275842A1 (en) * 2002-10-25 2004-05-13 Vasogen Ireland Limited Cyclooxygenase regulation with pg liposomes
WO2004082688A1 (en) * 2003-03-20 2004-09-30 Vasogen Ireland Limited Phosphatidylglycerol (pg) receptor agonists and antagonists
JP4669665B2 (ja) * 2004-04-12 2011-04-13 正彦 阿部 細胞毒性のないポリカチオン修飾リポソームおよびその製造方法
US8808715B1 (en) * 2004-11-23 2014-08-19 Georgia Regents Research Institute, Inc Methods and compositions for modulating keratinocyte function
US20070071805A1 (en) * 2005-09-26 2007-03-29 Vasogen Ireland Ltd. Treatment of inflammation and vascular abnormalities of the eye
CU23411B6 (es) * 2005-12-29 2009-09-08 Ct Ingenieria Genetica Biotech Uso tópico del factor de crecimiento epidérmico en liposomas para prevenir la amputación del pie diabético
CU23388B6 (es) 2006-01-31 2009-07-16 Ct Ingenieria Genetica Biotech Composición farmacéutica de microesferas para prevenir la amputación del pie diabético
ES2284398B2 (es) * 2006-04-27 2008-12-16 Universidad Complutense De Madrid Formulacion de vesiculas liposomales en soluciones acuosas con caracteristicas de pelicula lagrimal.
KR100752990B1 (ko) * 2006-08-02 2007-08-30 주식회사 대웅 나노리포좀 및 천연 추출물을 포함하는 피부 질환의 예방또는 치료용 조성물
WO2009107753A1 (ja) * 2008-02-29 2009-09-03 財団法人 名古屋産業科学研究所 後眼部到達用リポソーム及び後眼部疾患用医薬組成物
KR20100127842A (ko) * 2008-03-26 2010-12-06 유니버시티 오브 옥스퍼드 소포체 표적화 리포좀
EP2123258A1 (en) * 2008-05-23 2009-11-25 Liplasome Pharma A/S Liposomes for drug delivery
US8703744B2 (en) 2009-03-27 2014-04-22 The Chancellor, Masters And Scholars Of The University Of Oxford Cholesterol level lowering liposomes
US11052158B2 (en) * 2016-08-18 2021-07-06 Troy Bremer Delivery of urea to cells of the macula and retina using liposome constructs

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2540381B1 (fr) * 1983-02-08 1986-05-30 Dior Sa Parfums Christian Procede pour stimuler la croissance des cellules; composition cosmetique, pharmaceutique et composition complementaire pour milieu de culture cellulaire appliquant ce procede
US4708861A (en) * 1984-02-15 1987-11-24 The Liposome Company, Inc. Liposome-gel compositions
US4692454A (en) * 1986-02-03 1987-09-08 Warner-Lambert Company Opthalmic use of quinolone antibiotics
JPH02500360A (ja) * 1986-07-28 1990-02-08 リポソーム　テクノロジー，インコーポレイテッド 粘膜組織上での高い保持力を有するリポソーム
US4839175A (en) * 1986-07-28 1989-06-13 Liposome Technology, Inc. Liposomes with enhanced retention on mucosal tissue
US4752425A (en) * 1986-09-18 1988-06-21 Liposome Technology, Inc. High-encapsulation liposome processing method
US5064655A (en) * 1989-02-24 1991-11-12 Liposome Technology, Inc. Liposome gel composition and method

Also Published As

Publication number Publication date
AU5429790A (en) 1990-11-05
KR920700691A (ko) 1992-08-10
EP0465588A4 (en) 1992-06-03
IL93996A0 (en) 1991-01-31
JPH04505319A (ja) 1992-09-17
EP0465588A1 (en) 1992-01-15
AU633078B2 (en) 1993-01-21
CA2013770A1 (en) 1990-10-04
WO1990011781A1 (en) 1990-10-18

Similar Documents

Publication Publication Date Title
ZA902593B (en) The use of liposomes for the delivery of therapeutic agents to wounds,cuts and abrasions
NZ228564A (en) Corticosteroid-containing skin care composition for use as moisturiser: preparation thereof
AU4778893A (en) System of drug delivery to the lymphatic tissues
EP0412350A3 (en) Renininhibitors, procedure for their preparation and use as medicaments
ZA874251B (en) Therapeutic agent for skin ulcers
AU590783B2 (en) Therapeutic agent for treating hematopoietic diseases
GR3030150T3 (en) Use of Human Interferon-Beta 2A for the preparation of medicaments
ZA863900B (en) Use of benzopyran compounds in the treatment of incontinence
PT86205A (en) Process for the preparation of 3-]omega-(3,5-di-t-butil-4-hydroxyphenyl)-alkanoyl"pyrroles and their de-oxy analogs useful in therapy
GR3036384T3 (en) Medicament form for the delivery of collagenase to wounds and process for the preparation thereof
IL115652A (en) Use of vWF or fragments thereof for the preparation of medicaments having an antidote effect to antithrombotic and/or fibrinolytic agents producing hemorrhages
ZA938898B (en) Use of certain methanebisphosphonic acid derivatives in fracture healing
GR862249B (en) Dihydropyridin-2-hydroxyamine process for their preparation and their use as medicaments
EP0343671A3 (en) Pharmaceutical composition for the treatment of skin wounds
GB2170403B (en) Medicament for treatment of asthma and preparation thereof
GB8911259D0 (en) Inhalation medicament
ZA855137B (en) Bandage for sustained delivery of drugs
AU3764689A (en) Use of local anaesthetic agents in the manufacture of preparations with wound healing effect
NZ271496A (en) Treating hiv; use of azaspirane compounds to manufacture medicaments
ZA86365B (en) Use of sulphanyldihydropyridines as medicaments for the treatment of asthma
ZA905715B (en) 2-amino-7-carbamoyl-1,2,3,4-tetrahydronaphthalenes,processes for their preparation and their use as medicaments
AU3406389A (en) Synergistic combinations of beta-mimetic compounds and PAF-antagonists and their use as therapeutic agents
AU1778088A (en) Use of analgesic anti-inflammatory drugs in treating haemorrhoidal bleeding
GB8918242D0 (en) Preparation of agents for use in therapy
GR861057B (en) (aminoalkylthio)hydroxydibenzoxepins process for their preparation and their use as medicaments